Squibb
Oct 27, 2010 at 08:14 | Source: Reuters
Oct 18, 2010 at 19:14 | Source: CNBC-TV18
Oct 09, 2010 at 11:13 | Source: Reuters
Sep 08, 2010 at 08:30 | Source: Reuters
Nov 30, 2009 at 10:04 | Source: Reuters
News across the web »
May 26, 2012 at 00:36 | Source: Business Standard
May 18, 2012 at 16:36 | Source: The Hindu BusinessLine
May 18, 2012 at 10:00 | Source: Business Week
May 17, 2012 at 12:01 | Source: Stock Market Digital
May 17, 2012 at 02:41 | Source: Business Standard
Interact & exchange stock tips & market info »
Related News »
Bristol-Myers Squibb Company (BMS) discovers, develops, licenses, manufactures and markets biopharmaceuticals and related healthcare products. It principally offers products in the fields of cancer, infectious diseases, psychiatry disorders, diabetes ...
May 20, 2012 at 18:11 | Source: Transworld News
Pharmaceuticals giant Bristol Myers Squibb Co. (BMY) on Friday caught some bullish commentary from analysts at BMO Capital. The firm initiated coverage on BMY with an “Outperform” rating and $39 price target, which suggests a 19% upside to ...
May 18, 2012 at 13:06 | Source: dividend.com
SHANGHAI, China, May 15, 2012 (BUSINESS WIRE) -- The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes(R) initiative to China and India, pledging $15 million over five years to help these developing nations with ...
May 15, 2012 at 13:59 | Source: CNBC
Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA ® (abatacept).
May 16, 2012 at 08:43 | Source: News-Medical.Net
Bristol-Myers Squibb Company (NYSE: BMY - News) today announced that the company will present 18 abstracts on ORENCIA ® (abatacept) at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Berlin, June 6-9.
May 27, 2012 at 21:59 | Source: Yahoo Finance
PARIS, May 14, 2012 /PRNewswire via COMTEX/ -- Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment of moderate to severe rheumatoid arthritis to be presented Bristol-Myers Squibb Company ...
May 14, 2012 at 11:52 | Source: Marketwatch
The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes ® initiative to China and India, pledging $15 million over five years to help these developing nations with rapidly growing numbers of type 2 diabetes ...
May 27, 2012 at 23:54 | Source: Yahoo Finance
Last week the folks behind Brooklyn Heights Blog launched a Facebook page called “Rename Squibb Park in Brooklyn Heights To Honor Adam Yauch.” The idea was brought up by a commenter on the blog as a way to pay homage to the rapper, film director ...
May 25, 2012 at 20:57 | Source: POLLSTAR
NEW YORK, May 15, 2012 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial ...
May 15, 2012 at 14:57 | Source: CNBC
Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment of moderate to severe rheumatoid arthritis to be presented "The data being presented highlight Bristol-Myers Squibb's continued ...
May 14, 2012 at 11:59 | Source: International Business Times